| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.27 | 2e-12 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.24 | 6e-10 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.22 | 3e-09 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-06 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-05 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-05 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-05 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-05 |